{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:10:28Z","timestamp":1790493028039,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-006131"],"award-info":[{"award-number":["INV-006131"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OD024917"],"award-info":[{"award-number":["OD024917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["62\/994,630"],"award-info":[{"award-number":["62\/994,630"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["62\/969,008"],"award-info":[{"award-number":["62\/969,008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI126603"],"award-info":[{"award-number":["AI126603"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI124377"],"award-info":[{"award-number":["AI124377"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI129797"],"award-info":[{"award-number":["AI129797"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI128751"],"award-info":[{"award-number":["AI128751"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012802","name":"Ragon Institute of MGH, MIT and Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.chom.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:54:55Z","timestamp":1597053295000},"page":"364-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Approaches and Challenges in SARS-CoV-2 Vaccine Development"],"prefix":"10.1016","volume":"28","author":[{"given":"Gabriel","family":"Dagotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1016\/j.febslet.2006.06.002","article-title":"Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies","volume":"580","author":"Akerstr\u00f6m","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chom.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"eabd6160","DOI":"10.1126\/sciimmunol.abd6160","article-title":"SARS-CoV-2 T\u00a0cell immunity: Specificity, function, durability, and role in protection","volume":"5","author":"Altmann","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.chom.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility","volume":"382","author":"Arons","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2222.1990.tb02774.x","article-title":"The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers","volume":"20","author":"Barrow","year":"1990","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.chom.2020.08.002_bib5","first-page":"eabd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/bmj.3.5568.767","article-title":"Effects of a \u201cnew\u201d human respiratory virus in volunteers","volume":"3","author":"Bradburne","year":"1967","journal-title":"BMJ"},{"key":"10.1016\/j.chom.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S0022172400062410","article-title":"Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection","volume":"95","author":"Callow","year":"1985","journal-title":"J.\u00a0Hyg. (Lond.)"},{"key":"10.1016\/j.chom.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1128\/JVI.00527-07","article-title":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome","volume":"81","author":"Cameron","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.08.002_bib10","first-page":"eabc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.chom.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"129","author":"Channappanavar","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chom.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong. European journal of clinical microbiology & infectious diseases","volume":"24","author":"Cheng","year":"2005","journal-title":"European Society of Clinical Microbiology"},{"key":"10.1016\/j.chom.2020.08.002_bib15","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","author":"Corbett","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.chom.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1358\/dot.2008.44.1.1131830","article-title":"Development of subunit vaccines against severe acute respiratory syndrome","volume":"44","author":"Du","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.chom.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chom.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virusres.2007.01.021","article-title":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease","volume":"133","author":"Enjuanes","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.chom.2020.08.002_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.08.002_bib22","doi-asserted-by":"crossref","first-page":"e1000849","DOI":"10.1371\/journal.ppat.1000849","article-title":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism","volume":"6","author":"Frieman","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.08.002_bib25","first-page":"eabd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.chom.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"e4180","DOI":"10.1371\/journal.pone.0004180","article-title":"A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination","volume":"4","author":"Huang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.chom.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.08.002_bib30","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","author":"Jackson","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib31","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3346\/jkms.2016.31.11.1717","article-title":"Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection","volume":"31","author":"Kim","year":"2016","journal-title":"J.\u00a0Korean Med. Sci."},{"key":"10.1016\/j.chom.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"15701","DOI":"10.1038\/s41598-018-34171-7","article-title":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis","volume":"8","author":"Kirchdoerfer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.vaccine.2006.01.058","article-title":"Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates","volume":"24","author":"Liu","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jviromet.2008.08.011","article-title":"Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice","volume":"154","author":"Luo","year":"2008","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.chom.2020.08.002_bib38","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid-19 Vaccines at Pandemic Speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib39","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib40","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa2005412","article-title":"Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington","volume":"382","author":"McMichael","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib42","article-title":"Phase 1\/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report","author":"Mulligan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.chom.2020.08.002_bib43","article-title":"Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2","author":"Munster","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.chom.2020.08.002_bib44","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/JCM.01368-15","article-title":"Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia","volume":"53","author":"Muth","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.chom.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2020.08.002_bib47","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2020.08.002_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2020.08.002_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00253-004-1869-y","article-title":"Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination","volume":"68","author":"Pei","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.chom.2020.08.002_bib50","article-title":"The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement","author":"Quinlan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.chom.2020.08.002_bib51","doi-asserted-by":"crossref","first-page":"eabc3539","DOI":"10.1126\/scitranslmed.abc3539","article-title":"Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits","volume":"12","author":"Ravichandran","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/500143","article-title":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters","volume":"193","author":"Roberts","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2020.08.002_bib53","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.abb7314","article-title":"Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model","volume":"368","author":"Rockx","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib54","first-page":"eabc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1586\/erv.09.43","article-title":"SARS vaccines: where are we?","volume":"8","author":"Roper","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.chom.2020.08.002_bib56","doi-asserted-by":"crossref","first-page":"104791","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.chom.2020.08.002_bib57","article-title":"Robust T\u00a0cell immunity in convalescent individuals with asymptomatic or mild COVID-19","author":"Sekine","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.chom.2020.08.002_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.chom.2020.08.002_bib60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/v12040360","article-title":"Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins","volume":"12","author":"Srinivasan","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.chom.2020.08.002_bib61","doi-asserted-by":"crossref","first-page":"107863","DOI":"10.1016\/j.celrep.2020.107863","article-title":"Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells","volume":"32","author":"Stanifer","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2020.08.002_bib62","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib63","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib64","article-title":"The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severity","author":"Thieme","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.chom.2020.08.002_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib66","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib67","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4161\/hv.26009","article-title":"Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)","volume":"9","author":"Wallace","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.chom.2020.08.002_bib68","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","article-title":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion","volume":"176","author":"Walls","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.08.002_bib69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.08.002_bib70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry","volume":"94","author":"Wan","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib71","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1373\/clinchem.2003.023184","article-title":"Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus","volume":"49","author":"Wang","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.chom.2020.08.002_bib72","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chom.2020.08.002_bib73","article-title":"Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.08.002_bib74","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib75","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib77","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for Gastrointestinal Infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2020.08.002_bib78","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.08.002_bib79","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib80","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chom.2020.08.002_bib81","first-page":"eabc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.08.002_bib82","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbrc.2015.11.057","article-title":"IL-9 antibody injection suppresses the inflammation in colitis mice","volume":"468","author":"Yuan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chom.2020.08.002_bib83","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2020.08.002_bib84","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2020.08.002_bib85","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.08.002_bib86","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.08.002_bib87","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.08.002_bib88","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41577-020-0359-5","article-title":"Dissecting antibody-mediated protection against SARS-CoV-2","volume":"20","author":"Zohar","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.chom.2020.08.002_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","author":"Zost","year":"2020","journal-title":"Nature"}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312820304558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312820304558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:08:47Z","timestamp":1778832527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312820304558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1931312820304558"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2020.08.002","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approaches and Challenges in SARS-CoV-2 Vaccine Development","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}